Live feed
Filing
SC 13G
SC 13G0000902664-21-001692·BriaCell Therapeutics Corp.
Schedule 13G ownership disclosure
BRIACELL THERAPEUTICS ORD
Security class unavailable · CUSIP: 10778Y302
Event date: 2021-02-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 500,000
- Percent of class
- 8.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-001692
- Form type
- SC 13G
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- Mar 02, 2021
- Reporting period
- Feb 23, 2021
- Description
- Schedule 13G beneficial ownership